2019
DOI: 10.1007/s11060-019-03110-5
|View full text |Cite
|
Sign up to set email alerts
|

Race influences survival in glioblastoma patients with KPS ≥ 80 and associates with genetic markers of retinoic acid metabolism

Abstract: Purpose: To study whether the clinical outcome and molecular biology of gliomas in African-American patients fundamentally differ from those occurring in Whites. Methods: The clinical information and molecular profiles (including gene expression array, nonsilent somatic mutation, DNA methylation and protein expression) were downloaded from The Cancer Genome Atlas (TCGA). Electronic medical records were abstracted from Northwestern Medicine Enterprise Data Warehouse (NMEDW) for analysis as well. Grade II-IV Gli… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
12
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 20 publications
(12 citation statements)
references
References 37 publications
0
12
0
Order By: Relevance
“…First, our data highlight that expression of the pseudogene, CRYβB2P1, is associated with Black/African-American breast cancer patients compared to White and Asian patient samples, and CRYβB2P1 expression levels are higher compared to CRYβB2 in all TCGA breast cancer samples. Other studies have highlighted CRYβB2 as a health disparity gene in breast cancer, but our data suggest technical difficulties in distinguishing between the expression levels of the two genes and that the more likely disparity target is CRYβB2P1 [7, 11, 12, 1417]. Second, our data suggest CRYβB2P1 functions as a ncRNA in triple-negative breast cancers to alter transcription.…”
Section: Discussionmentioning
confidence: 56%
See 1 more Smart Citation
“…First, our data highlight that expression of the pseudogene, CRYβB2P1, is associated with Black/African-American breast cancer patients compared to White and Asian patient samples, and CRYβB2P1 expression levels are higher compared to CRYβB2 in all TCGA breast cancer samples. Other studies have highlighted CRYβB2 as a health disparity gene in breast cancer, but our data suggest technical difficulties in distinguishing between the expression levels of the two genes and that the more likely disparity target is CRYβB2P1 [7, 11, 12, 1417]. Second, our data suggest CRYβB2P1 functions as a ncRNA in triple-negative breast cancers to alter transcription.…”
Section: Discussionmentioning
confidence: 56%
“…Crystallin β B2 (CRYβB2) has recently drawn particular interest because of its genetic association with overall survival and African-American ethnicity in multiple cancers, including breast, colorectal, renal cell carcinoma, glioblastoma, and prostate tumors [7, 11, 12, 1417]. In a small prediction analysis study, 91% of all African-American/Black patients ( n = 33) and 94% of all White patients ( n = 36) were correctly classified according to race using CRYβB2 as one of the two-gene signatures in prostate tumors, PSPHL being the other gene classifier [12].…”
Section: Introductionmentioning
confidence: 99%
“…Human genetics contribute to the propensity and severity of diseases 21,[30][31][32][33][34][35][36][37] . Sometimes the contribution is straightforward; a single allele variation found in Ashkenazi Jews, causes the vast majority of Tay-Sachs disease 36 .…”
Section: Discussionmentioning
confidence: 99%
“…Genetics of human populations contribute to the propensity and severity of diseases 37,39,41,41,45,[93][94][95][96][97][98] . Sometimes the contribution is straightforward; a single allele variation found in Ashkenazi Jews, causes the vast majority of Tay-Sachs disease 99 .…”
Section: Discussionmentioning
confidence: 99%